Meredith A. Cowden Foundation
Lyn M. Haselton currently serves as the National GvHD Symposium Executive Director and Executive Coordinator at the Meredith A. Cowden Foundation, a role focused on advancing research and treatment for Graft-versus-host disease through a conference tailored for both healthcare professionals and patients. Previously, Lyn M. Haselton held the position of Research Program Director at Summa Health, overseeing projects in the Emergency Department and Women's Health. Additional experience includes serving as a Graduate Teaching Assistant at Kent State University, managing special projects and training programs at Case Western Reserve University's Case Comprehensive Cancer Center, and engaging in research at the Cleveland Clinic's Neuromodulation Research Center. Educational credentials include a PhD in Public Health with a focus on Prevention Science from Kent State University, a Master of Public Administration in Healthcare Administration from Cleveland State University, and a Bachelor of Science in Pre-Medicine from Cleveland State University.
This person is not in the org chart
This person is not in any teams
Meredith A. Cowden Foundation
The mission of the Meredith A. Cowden Foundation is to increase the number of blood and marrow transplant survivors, to raise awareness of transplant complications and late effects, and to reduce their impact. The Meredith A. Cowden Foundation is committed to: 1. Providing funding for research to prevent, treat and cure Graft vs. Host Disease (GVHD) 2. Educating physicians, researchers, patients, and the general public concerning GVHD and late effects of transplants, their prevention, treatment and cure 3. Providing general information concerning the blood cancers and their treatment, with a special emphasis on the treatment of leukemia and bone marrow and stem cell transplantation 4. Providing resources to support programs designed to enhance the quality of life of patients and their families during treatment For over a decade, the Foundation has hosted a unique conference where physicians, mid-level medical personnel, patients, and their caregivers and family come together to receive the best current information concerning the treatment of GVHD and late effects. For more information, visit http://www.cowdenfoundation.org.